TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10426331

Group type: EXPERIMENTAL
Intervention: Magnesium oxide tablets (800 to 1,200 mg/day)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 7500451

Group type: EXPERIMENTAL
Intervention: Continuous bladder irrigation with 50 mg/l amphotericin B infused during 24 hours for 2 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intermittent bladder irrigations of 10 mg/100 ml amphotericin B in 1 day
Number of subjects: 20
Study: 2104135

Group type: EXPERIMENTAL
Intervention: Amoxicillin/clavulanic acid (A/Cl) for 10 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: Trimethoprim (TMP) for 10 days
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Amoxicillin/clavulanic acid (A/Cl) for 3 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: Trimethoprim (TMP) as a single dose
Number of subjects: 80
Study: 6105556

Group type: EXPERIMENTAL
Intervention: Coronary bypass surgery
Number of subjects: 768

Group type: COMPARATOR
Intervention: No surgery (medical treatment)
Number of subjects: 768
Study: 31836291

Group type: EXPERIMENTAL
Intervention: Intraperitoneal lavage with 50 mL of 0.2% bupivacaine
Number of subjects: 106

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 106
Study: 31718439

Group type: EXPERIMENTAL
Intervention: FFR-guided revascularization
Number of subjects: 216

Group type: COMPARATOR
Intervention: Angiography guided
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Deferred lesions based on FFR
Number of subjects: 216

Group type: COMPARATOR
Intervention: Angiography guided percutaneous coronary intervention
Number of subjects: 216
Study: 28353221

Group type: EXPERIMENTAL
Intervention: PEG-IFN-free regimens (sofosbuvir + ledipasvir with or without ribavirin)
Number of subjects: 43

Group type: COMPARATOR
Intervention: PEG-IFN-containing treatment
Number of subjects: 43
Study: 25886874

Group type: EXPERIMENTAL
Intervention: etoricoxib 10/30/60 mg
Number of subjects: 761

Group type: EXPERIMENTAL
Intervention: etoricoxib 90 mg
Number of subjects: 761

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 761
Study: 23536466

Group type: EXPERIMENTAL
Intervention: L-protocol (lengthening exercises)
Number of subjects: 75

Group type: COMPARATOR
Intervention: C-protocol (conventional exercises)
Number of subjects: 75
Study: 21236405

Group type: EXPERIMENTAL
Intervention: Mitomycin C applied on the perilimbal sclera (sclera group)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Mitomycin C applied under conjunctiva (subconjunctiva group)
Number of subjects: 56
Study: 19185400

Group type: EXPERIMENTAL
Intervention: Calcium (1,200 mg) and vitamin D(3) (800 IU) supplementation
Number of subjects: 639

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 639
Study: 17539788

Group type: EXPERIMENTAL
Intervention: Aspherical IOL Z9001
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Monofocal IOL SA60AT
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Multifocal IOL SA40N
Number of subjects: 124
Study: 15355651

Group type: EXPERIMENTAL
Intervention: Brachy-chemotherapy group (n = 18)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (n = 18)
Number of subjects: 36
Study: 11493740

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight HES preparation (6% HES, MW 70,000)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Gelatin (3% gelatin, MW 35,000)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Medium-molecular-weight HES preparation (6% HES, MW 200,000/0.5)
Number of subjects: 40

Group type: COMPARATOR
Intervention: High-molecular-weight HES preparation (6% HES, MW 450,000/0.7)
Number of subjects: 40
Study: 9615959

Group type: EXPERIMENTAL
Intervention: Speech therapy focusing on respiration, loudness, articulation, prosody, and intonation
Number of subjects: 0
Study: 9093728

Group type: EXPERIMENTAL
Intervention: Continuation of oral 5-HT3 antagonists (ondansetron 8 mg b.i.d. or dolasetron 200 mg daily) plus dexamethasone 8 mg p.o. daily
Number of subjects: 407

Group type: COMPARATOR
Intervention: Dexamethasone alone
Number of subjects: 407
Study: 2202553

Group type: EXPERIMENTAL
Intervention: 2.5% percutaneous niflumic acid gel applied 3-times daily for 7 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo gel applied 3-times daily for 7 days
Number of subjects: 60
Study: 6786825

Group type: EXPERIMENTAL
Intervention: Norethisterone Enanthate (NEN)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Norethisterone Acetate (NET)
Number of subjects: 20
Study: 30850868

Group type: EXPERIMENTAL
Intervention: Metronome guidance at 110 beats/min (test 2)
Number of subjects: 36

Group type: COMPARATOR
Intervention: No metronome guidance (baseline test/test 1)
Number of subjects: 36
Study: 27837524

Group type: EXPERIMENTAL
Intervention: 150 min/week aerobic exercise (moderate volume group)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: 300 min/week aerobic exercise (high volume group)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Higher volume of aerobic exercise
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Marital status as a moderator
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Obesity as a moderator
Number of subjects: 400
Study: 26450209

Group type: EXPERIMENTAL
Intervention: Math story time with parents using an iPad app
Number of subjects: 587

Group type: COMPARATOR
Intervention: Reading (control group)
Number of subjects: 587
Study: 23770110

Group type: EXPERIMENTAL
Intervention: Self-management training sessions with individualized action plans for COPD and comorbidities, linked to daily symptom diaries for 12 months.
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (usual care with COPD action plans).
Number of subjects: 300
Study: 21917304

Group type: EXPERIMENTAL
Intervention: Tamsulosin oral controlled absorption system 0.4 mg/d for 1 month
Number of subjects: 248

Group type: COMPARATOR
Intervention: Standard medical care (corticosteroids and analgesics)
Number of subjects: 248
Study: 18215978

Group type: EXPERIMENTAL
Intervention: EFV+IDV
Number of subjects: 283

Group type: COMPARATOR
Intervention: EFV+IDV plus ABC
Number of subjects: 283
Study: 17003662

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 7
Study: 14637325

Group type: EXPERIMENTAL
Intervention: Pressuring strategies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Feeling and looking good strategies
Number of subjects: 0
Study: 10913922

Group type: EXPERIMENTAL
Intervention: Fracture group (31 women)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Nonfracture group (22 women)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Fracture group (men)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Nonfracture group (men)
Number of subjects: 53
Study: 8908377

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 60

Group type: COMPARATOR
Intervention: DNA-recombinant insulin
Number of subjects: 60
Study: 1929843

Group type: EXPERIMENTAL
Intervention: Computed tomography (CT) evaluation in 31 patients
Number of subjects: 85

Group type: COMPARATOR
Intervention: Conventional evaluation in 30 patients
Number of subjects: 85
Study: 6126126

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 7

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 7
Study: 31915175

Group type: EXPERIMENTAL
Intervention: Early integration of palliative care (EIPC) on a monthly basis
Number of subjects: 214

Group type: COMPARATOR
Intervention: Optimised standard care (control group)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Early integration of palliative care (EIPC)
Number of subjects: 214
Study: 30828820

Group type: EXPERIMENTAL
Intervention: Provision of accurate information about the proportion of whole blood donors who experience faint and prefaint reactions
Number of subjects: 3702

Group type: COMPARATOR
Intervention: Control group (no accurate information provided)
Number of subjects: 3702
Study: 28943117

Group type: EXPERIMENTAL
Intervention: 14% benzocaine alone
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 14% benzocaine plus 2% tetracaine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 0.4 mL of 14% benzocaine plus 0.2% benzocaine
Number of subjects: 40
Study: 24720763

Group type: EXPERIMENTAL
Intervention: FIO2 0.3 before removal of the LMA
Number of subjects: 60

Group type: COMPARATOR
Intervention: FIO2 1.0 before removal of the LMA
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Post-hoc analysis
Number of subjects: 60
Study: 21555333

Group type: EXPERIMENTAL
Intervention: Alcohol (mean breath alcohol concentration = 68 mg/dL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No-alcohol control (0 mg/dL)
Number of subjects: 30
Study: 19440173

Group type: EXPERIMENTAL
Intervention: Polyurethane dressing
Number of subjects: 60

Group type: COMPARATOR
Intervention: Silicone sheet
Number of subjects: 60
Study: 17894701

Group type: EXPERIMENTAL
Intervention: Pimecrolimus cream (1%)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 40
Study: 15193942

Group type: EXPERIMENTAL
Intervention: Hybrid sequences
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ambiguous sequences
Number of subjects: 12
Study: 11533310

Group type: EXPERIMENTAL
Intervention: Glutamine supplementation
Number of subjects: 0
Study: 9504867

Group type: EXPERIMENTAL
Intervention: 13N-ammonia PET
Number of subjects: 31

Group type: COMPARATOR
Intervention: 99mTc-sestamibi SPECT
Number of subjects: 31
Study: 8137435

Group type: EXPERIMENTAL
Intervention: HLA‐A,‐B and HLA‐DR antigen matching
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Positive crossmatch donor
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: ABO-compatible group
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: ABO-incompatible group
Number of subjects: 456
Study: 2701744

Group type: EXPERIMENTAL
Intervention: Milnacipran
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 27854116

Group type: EXPERIMENTAL
Intervention: 100% orange juice with vitamin C 70 mg daily (G2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (G1)
Number of subjects: 60
Study: 31766987

Group type: EXPERIMENTAL
Intervention: Classroom-based sexual assault prevention program (IMPower and Sources of Strength)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 31239304

Group type: EXPERIMENTAL
Intervention: Albuterol inhaled with gas flow of 50 L/min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Albuterol inhaled with GF:IF=1.0
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Albuterol inhaled with GF:IF=0.5
Number of subjects: 0

Group type: COMPARATOR
Intervention: 2 mL saline inhaled before albuterol doses
Number of subjects: 0
Study: 28285649

Group type: EXPERIMENTAL
Intervention: Pioglitazone (PIO) treatment for 12 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (CON)
Number of subjects: 24
Study: 25956370

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA) and hMG administered simultaneously
Number of subjects: 300

Group type: COMPARATOR
Intervention: Short protocol (control group)
Number of subjects: 300
Study: 23942523

Group type: EXPERIMENTAL
Intervention: Web-based personally controlled health management system (PCHMS) called Healthy.me
Number of subjects: 300

Group type: COMPARATOR
Intervention: Information websites (usual care arm)
Number of subjects: 300
Study: 21155616

Group type: EXPERIMENTAL
Intervention: Manidipine 20 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Manidipine 10 mg/Lisinopril 10 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Amlodipine 10 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Telmisartan 80 mg
Number of subjects: 120
Study: 19221241

Group type: EXPERIMENTAL
Intervention: Contrasted test (modified distractors)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Classic test (standard distractors)
Number of subjects: 30
Study: 16847409

Group type: EXPERIMENTAL
Intervention: Abrupt weaning
Number of subjects: 222

Group type: COMPARATOR
Intervention: Breastfeeding (control)
Number of subjects: 222
Study: 12490768

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 10792142

Group type: EXPERIMENTAL
Intervention: 1.0 microgram.kg‐1 intravenous fentanyl
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 9497468

Group type: COMPARATOR
Intervention: Gas tamponade alone (20% SF6)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Gas tamponade with TGF-beta 2 (20% SF6 gas + TGF-beta 2)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Gas tamponade with autologous platelet concentrate (16% C3F8 gas + 0.1 ml autologous platelet concentrate)
Number of subjects: 85
Study: 7686981

Group type: EXPERIMENTAL
Intervention: Leuprolide (luteinizing hormone-releasing hormone agonist) given as an injection every 28 days for 24 weeks
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Leuprolide (luteinizing hormone-releasing hormone agonist)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 3092689

Group type: EXPERIMENTAL
Intervention: Nebulised sodium cromoglycate (SCG)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 29991458

Group type: EXPERIMENTAL
Intervention: FIT
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: WBV
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control
Number of subjects: 200
Study: 27814472

Group type: EXPERIMENTAL
Intervention: Selenium (200 μg once a day)
Number of subjects: 292

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 292
Study: 25480461

Group type: EXPERIMENTAL
Intervention: Web-based intervention
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Print-mailed intervention
Number of subjects: 289

Group type: COMPARATOR
Intervention: Standard advice
Number of subjects: 289
Study: 23390825

Group type: EXPERIMENTAL
Intervention: Spinal Anesthesia (SA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 40
Study: 20846063

Group type: EXPERIMENTAL
Intervention: Training with professional patients
Number of subjects: 87

Group type: COMPARATOR
Intervention: Training with clinical patients
Number of subjects: 87
Study: 17570513

Group type: EXPERIMENTAL
Intervention: Fludarabine 30 mg/m² for 6 days and oral busulfan 4 mg/kg/day for 2 days
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Fludarabine and busulfan regimen
Number of subjects: 30
Study: 16088264

Group type: EXPERIMENTAL
Intervention: Behavior Therapy (BT)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (FLV)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (autogenic training +/− pill placebo)
Number of subjects: 31
Study: 12187208

Group type: EXPERIMENTAL
Intervention: Monthly leuprolide acetate (7.5 mg)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: 3-month leuprolide acetate (22.5 mg)
Number of subjects: 71
Study: 10442361

Group type: EXPERIMENTAL
Intervention: Oxaliplatin and UFT/oral calcium folinate
Number of subjects: 0

Group type: COMPARATOR
Intervention: UFT/oral calcium folinate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oxaliplatin
Number of subjects: 0
Study: 7587986

Group type: EXPERIMENTAL
Intervention: Finasteride (Proscar ‐ MSD)
Number of subjects: 0
Study: 2132171

Group type: EXPERIMENTAL
Intervention: Ketanserin (0.1 mg/min for 24 h)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 43
Study: 786666

Group type: EXPERIMENTAL
Intervention: Azathioprine (AZ) 1.5 ‐ 2.0 mg/kg/day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Azathioprine (AZ)
Number of subjects: 30
Study: 31034342

Group type: EXPERIMENTAL
Intervention: Below-knee compression garments
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control (no compression garments)
Number of subjects: 41
Study: 29037178

Group type: EXPERIMENTAL
Intervention: Smartphone website
Number of subjects: 145

Group type: COMPARATOR
Intervention: Leaflet
Number of subjects: 145
Study: 25175277

Group type: EXPERIMENTAL
Intervention: High verbal patient-centeredness
Number of subjects: 192

Group type: COMPARATOR
Intervention: Low verbal patient-centeredness
Number of subjects: 192
Study: 22820210

Group type: EXPERIMENTAL
Intervention: Topical cooling
Number of subjects: 11
Study: 22165364

Group type: EXPERIMENTAL
Intervention: Levitan scope (Phase 1)
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Bonfils scope (Phase 1)
Number of subjects: 324

Group type: COMPARATOR
Intervention: Levitan scope (Phase 2)
Number of subjects: 324

Group type: COMPARATOR
Intervention: Bonfils scope (Phase 2)
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Both scopes
Number of subjects: 324
Study: 19083502

Group type: EXPERIMENTAL
Intervention: Juvéderm Ultra
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Juvéderm Ultra Plus
Number of subjects: 292

Group type: COMPARATOR
Intervention: Zyplast collagen
Number of subjects: 292
Study: 16562817

Group type: EXPERIMENTAL
Intervention: Lean pork (150 g per day)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Veal (150 g per day)
Number of subjects: 44
Study: 12679825

Group type: EXPERIMENTAL
Intervention: Milk fermented with yoghurt cultures and L. casei DN‐114001 for 3 weeks
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 180
Study: 10980510

Group type: EXPERIMENTAL
Intervention: 3-kg small batch (I)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 50-kg large batch (II)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 80-kg large batch with high shear granulation and microwave drying (IV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3-kg small batch with fluid bed granulation and drying (III)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: multiparticulate capsule (V)
Number of subjects: 0
Study: 8741022

Group type: EXPERIMENTAL
Intervention: brofaromine
Number of subjects: 419

Group type: COMPARATOR
Intervention: imipramine
Number of subjects: 419

Group type: COMPARATOR
Intervention: Hamilton Depression Rating Scale
Number of subjects: 419

Group type: COMPARATOR
Intervention: von Zerssen Adjective Mood Scale
Number of subjects: 419
Study: 1426117

Group type: EXPERIMENTAL
Intervention: Sinusoidal treadmill movement at frequencies of 0.5, 0.33, and 0.25 Hz with a constant amplitude of +/- 12 cm.
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Adaptation to a new sinusoidal frequency occurred within 4 cycles following a change in sinus frequency.
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Postural adjustments during treadmill movement.
Number of subjects: 3
Study: 4096759

Group type: EXPERIMENTAL
Intervention: Phenobarbital
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (untreated infants)
Number of subjects: 19
Study: 29528443

Group type: EXPERIMENTAL
Intervention: Intraoperative radiotherapy (IORT) with 20 to 40 Gy of low-energy photons
Number of subjects: 15
Study: 30055579

Group type: EXPERIMENTAL
Intervention: Group Baby Triple P
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care as Usual (CAU)
Number of subjects: 0
Study: 26705972

Group type: EXPERIMENTAL
Intervention: Targeted temperature management at 33°C
Number of subjects: 0

Group type: COMPARATOR
Intervention: Targeted temperature management at 36°C
Number of subjects: 0
Study: 24760645

Group type: EXPERIMENTAL
Intervention: Early enteral nutrition (EEN)
Number of subjects: 60
Study: 23216787

Group type: EXPERIMENTAL
Intervention: Contact-based education sessions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Late intervention group (control)
Number of subjects: 0
Study: 21066905

Group type: EXPERIMENTAL
Intervention: Health promotion plus cognitive-behavioral skills building (CBSB)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Health promotion without CBSB
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Health promotion plus CBSB
Number of subjects: 268
Study: 16842480

Group type: EXPERIMENTAL
Intervention: Nateglinide plus metformin
Number of subjects: 262

Group type: COMPARATOR
Intervention: Gliclazide plus metformin
Number of subjects: 262
Study: 12927012

Group type: EXPERIMENTAL
Intervention: Active high-frequency (20-Hz) rTMS of left dorsolateral prefrontal cortex
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 14
Study: 10968597

Group type: EXPERIMENTAL
Intervention: Methergine
Number of subjects: 80

Group type: COMPARATOR
Intervention: No Methergine (Control)
Number of subjects: 80
Study: 9315418

Group type: EXPERIMENTAL
Intervention: Allendale-N9 film containing 100 mg N-9
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Allendale-N9 film containing 130 mg N-9
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: VCF containing 70 mg N-9
Number of subjects: 10

Group type: COMPARATOR
Intervention: Baseline cycles (no film used)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: All test cycles (Allendale-N9 and VCF)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Colposcopy
Number of subjects: 10
Study: 1587069

Group type: EXPERIMENTAL
Intervention: Oral diltiazem
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 2418670

Group type: EXPERIMENTAL
Intervention: All-paced (AP) group
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Sensed-paced (SP) group
Number of subjects: 15
Study: 30165595

Group type: EXPERIMENTAL
Intervention: Progressive Resistance Training (PRT) 3 d/wk for 12 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Home-based flexibility (FLEX) 3 d/wk for 12 weeks
Number of subjects: 70
Study: 29996792

Group type: EXPERIMENTAL
Intervention: Young Women's Health CoOp (YWHC) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard HCT (control)
Number of subjects: 0
Study: 26906148

Group type: EXPERIMENTAL
Intervention: Exercise Training (ET) on a cycle ergometer, performed daily at 50%-60% of maximal exercise capacity for 12 months.
Number of subjects: 37
Study: 25022743

Group type: EXPERIMENTAL
Intervention: Weighted blanket
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control blanket (usual weight blanket)
Number of subjects: 73
Study: 22327039

Group type: EXPERIMENTAL
Intervention: Oral CR oxycodone 10 mg/q12h plus IV paracetamol 1g/q6h
Number of subjects: 260

Group type: COMPARATOR
Intervention: Epidural anesthesia with continuous infusion of levobupivacaine 0.125% and sufentanil 0.7 mcg/mL at 7 mL/h
Number of subjects: 260